Lead sponsor
Kyowa Kirin Co., Ltd.
3 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
3
Trials led
0
Ongoing
98
Total enrollment
11
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
3
Trials by status
Completed
3
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Study of Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's Diseaseprodromal AD / mild-to-moderate ADPh 1Completed57
A Repeated Dose Study of KHK6640 in Japanese Patients With Alzheimer's Diseasemild-to-moderate ADPh 1Completed21
A Single Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease.mild-to-moderate ADPh 1Completed20